Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies
October 24, 2025 23:37 ET | Source: RepIntel. New York, New York,…
Prenetics Global Limited Announces Proposed Public Offering
October 24, 2025 20:30 ET | Source: Prenetics Global Limited CHARLOTTE, N.C.,…
K12 Wins Two Silver Medals at 2025 International Serious Play Awards
RESTON, VA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- K12, a national leader…
Hera & Circular Revolutionize Traceability & Transparency in Banking, Insurance, Agri-food, and Healthcare
Washington D.C., Oct. 24, 2025 (GLOBE NEWSWIRE) -- The strategic partnership between…
Surfshark launches a privacy-first web content blocker
Surfshark, a cybersecurity company, launches a new feature called the web content…
Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference
October 24, 2025 12:00 ET | Source: Flare Therapeutics Inc. FX-909, the…
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
New Clinical Data Confirms Yomi Robotic System Enhances Efficiency in Dental Implant Surgery
October 23, 2025 13:48 ET | Source: Neocis MIAMI, Oct. 23, 2025…
Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The award-winning film An Inconvenient…
